Healthcare provider profile · identity verified

Mario Eurico Ravry, M.D.

Internal Medicine · ATLANTA, GA · NPI 1922072321

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	541	127
Amlodipine Besylate	Amlodipine Besylate	413	108
Atorvastatin Calcium	Atorvastatin Calcium	393	113
Rosuvastatin Calcium	Rosuvastatin Calcium	375	108
Pantoprazole Sodium	Pantoprazole Sodium	370	109
Losartan Potassium	Losartan Potassium	335	86
Trazodone Hcl	Trazodone Hcl	311	80
Metformin Hcl	Metformin Hcl	279	76
Simvastatin	Simvastatin	256	67
Hydrochlorothiazide	Hydrochlorothiazide	221	55
Lisinopril	Lisinopril	203	56
Tamsulosin Hcl	Tamsulosin Hcl	202	53
Omeprazole	Omeprazole	200	55
Gabapentin	Gabapentin	192	61
Alprazolam	Alprazolam	191	47
Januvia	Sitagliptin Phosphate	180	36
Meloxicam	Meloxicam	167	48
Zolpidem Tartrate	Zolpidem Tartrate	160	38
Sertraline Hcl	Sertraline Hcl	157	36
Potassium Chloride	Potassium Chloride	138	31
Famotidine	Famotidine	135	40
Escitalopram Oxalate	Escitalopram Oxalate	134	32
Glimepiride	Glimepiride	120	31
Montelukast Sodium	Montelukast Sodium	119	28
Atenolol	Atenolol	112	30
Donepezil Hcl	Donepezil Hcl	112	30
Metoprolol Succinate	Metoprolol Succinate	110	29
Jardiance	Empagliflozin	107	23
Pravastatin Sodium	Pravastatin Sodium	107	26
Synthroid	Levothyroxine Sodium	107	21
Ipratropium Bromide	Ipratropium Bromide	105	36
Solifenacin Succinate	Solifenacin Succinate	100	29
Clonazepam	Clonazepam	98	20
Clopidogrel	Clopidogrel Bisulfate	96	25
Valsartan	Valsartan	94	24
Fluticasone Propionate	Fluticasone Propionate	92	40
Furosemide	Furosemide	92	26
Lorazepam	Lorazepam	91	22
Tramadol Hcl	Tramadol Hcl	91	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	86	24
Bupropion Xl	Bupropion Hcl	85	18
Celecoxib	Celecoxib	82	19
Primidone	Primidone	81	15
Allopurinol	Allopurinol	77	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	71	20
Esomeprazole Magnesium	Esomeprazole Magnesium	69	19
Benazepril Hcl	Benazepril Hcl	68	20
Citalopram Hbr	Citalopram Hydrobromide	68	16
Finasteride	Finasteride	67	21
Carvedilol	Carvedilol	66	13
Fluoxetine Hcl	Fluoxetine Hcl	66	14
Buspirone Hcl	Buspirone Hcl	64	22
Paroxetine Hcl	Paroxetine Hcl	64	19
Fenofibrate	Fenofibrate Nanocrystallized	62	15
Temazepam	Temazepam	62	suppressed
Valacyclovir	Valacyclovir Hcl	62	19
Memantine Hcl	Memantine Hcl	59	13
Linzess	Linaclotide	58	20
Mounjaro	Tirzepatide	58	suppressed
Pregabalin	Pregabalin	58	12
Olmesartan Medoxomil	Olmesartan Medoxomil	57	18
Eliquis	Apixaban	56	14
Ozempic	Semaglutide	56	12
Triamcinolone Acetonide	Triamcinolone Acetonide	56	38
Albuterol Sulfate Hfa	Albuterol Sulfate	55	34
Diclofenac Sodium	Diclofenac Sodium	55	21
Spironolactone	Spironolactone	55	19
Duloxetine Hcl	Duloxetine Hcl	53	21
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	52	17
Propranolol Hcl	Propranolol Hcl	51	13
Mirtazapine	Mirtazapine	50	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	50	11
Azithromycin	Azithromycin	49	47
Baclofen	Baclofen	49	25
Oxybutynin Chloride Er	Oxybutynin Chloride	49	suppressed
Estradiol	Estradiol	47	13
Hydralazine Hcl	Hydralazine Hcl	45	21
Breo Ellipta	Fluticasone/Vilanterol	44	11
Metoprolol Tartrate	Metoprolol Tartrate	44	13
Quetiapine Fumarate	Quetiapine Fumarate	44	13
Venlafaxine Hcl Er	Venlafaxine Hcl	44	11
Azelastine Hcl	Azelastine Hcl	42	15
Sucralfate	Sucralfate	42	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	28
Cefdinir	Cefdinir	40	35
Doxazosin Mesylate	Doxazosin Mesylate	39	13
Metformin Hcl Er	Metformin Hcl	39	suppressed
Colestipol Hcl	Colestipol Hcl	38	11
Ezetimibe	Ezetimibe	38	14
Methylprednisolone	Methylprednisolone	38	33
Oxybutynin Chloride	Oxybutynin Chloride	38	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	36	11
Liothyronine Sodium	Liothyronine Sodium	36	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	14
Premarin	Estrogens, Conjugated	34	suppressed
Megestrol Acetate	Megestrol Acetate	32	14
Colesevelam Hcl	Colesevelam Hcl	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	31	31
Hydrocortisone	Hydrocortisone	30	16
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	30	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Glipizide	Glipizide	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	21
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	16
Rybelsus	Semaglutide	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	16
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	22	suppressed
Doxepin Hcl	Doxepin Hcl	22	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Cefuroxime	Cefuroxime Axetil	20	20
Farxiga	Dapagliflozin Propanediol	20	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Raloxifene Hcl	Raloxifene Hcl	20	suppressed
Dutasteride	Dutasteride	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Prednisone	Prednisone	19	13
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Nystatin	Nystatin	17	11
Clonidine	Clonidine	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	14
Colchicine	Colchicine	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Diazepam	Diazepam	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Humulin R	Insulin Regular, Human	14	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Risperidone	Risperidone	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Sure Comfort	Pen Needle, Diabetic	14	suppressed
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	14	suppressed
Digoxin	Digoxin	13	suppressed
Nexium	Esomeprazole Magnesium	13	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Single Use Swab	Alcohol Antiseptic Pads	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Wegovy	Semaglutide	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error